GLP 1 Users Turn to Telehealth to Access Weight Loss Drugs Glucagon like peptide 1 (GLP 1) is a hormone that regulates blood sugar levels and promotes feelings of fullness.
Research has shown that GLP 1 receptor agonists can lead to significant reductions in body weight, often exceeding 10% of initial BMI.
The mechanism behind this effect involves slowing gastric emptying and reducing appetite. The rise of telehealth services has made it possible for people to access these medications without in person consultations.